Changing Lifestyles Help Market for Infertility Treatment

San Francisco, California, March 12, 2018: A recent market study by TMR Research, titled, “Infertility Treatment Market – Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth and Forecast 2017–2025,” finds that changing lifestyles leading to unhealthy eating patterns, dearth of physical activities, and excess stress related to work are hampering the healthy functioning of reproductive systems, thereby boosting the market. Rising instances of obesity and diabetes, along with environmental effects, are also creating problems in conceiving or giving birth, and this in turn is also upping demand for infertility treatments.

Mushrooming IVF centers and increasing capacity of people to spend on them is also catalyzing demand for infertility treatments. One drawback of the entire procedure is the stress it induces, especially after repeated attempts that do not fructify. This along with steep cost and social taboos related with infertility treatments are posing major challenge to the market. The popularity of Ayurveda or herbal infertility treatments in certain pockets of the world is another hurdle the market needs to overcome.

Get Sample Copy of this Report @

From a geographical standpoint, North America leads the global market for infertility treatment owing to a solid healthcare infrastructure and a large pool of people battling infertility. The positive approach towards such treatments has also proved beneficial for the market in the region. Europe and Asia pacific are other key markets. The market in Asia Pacific has an advantage on account of the large population size in countries such as China and India and also because of the increasing trend of marrying late.

The global market for infertility treatment is characterized by intense competition. Some of the players that have been able to thrive in such a cutthroat environment to emerge dominant are Labotect GmbH, Hamilton Throne Ltd., Microtech IVF s.r.o., Zander scientific Inc., and SoMATEX Medical Technologies GmbH, and INVO Bioscience.